EBP | Emopamil binding protein (sterol isomerase) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
EDNRA | Endothelin receptor type A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
EI24 | Etoposide induced 2.4 | Cancer-related genes Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 | G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Mixed |
EMC3 | ER membrane protein complex subunit 3 | Predicted membrane proteins
| | | | | Expressed in all |
ENDOD1 | Endonuclease domain containing 1 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
FAM189B | Family with sequence similarity 189, member B | Predicted membrane proteins
| | | | | Expressed in all |
FAM8A1 | Family with sequence similarity 8, member A1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
GABRB2 | Gamma-aminobutyric acid (GABA) A receptor, beta 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
GLP2R | Glucagon-like peptide 2 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPR108 | G protein-coupled receptor 108 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
GPR160 | G protein-coupled receptor 160 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
GPRC5B | G protein-coupled receptor, class C, group 5, member B | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GRIA1 | Glutamate receptor, ionotropic, AMPA 1 | FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
GRIA2 | Glutamate receptor, ionotropic, AMPA 2 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
GRIA3 | Glutamate receptor, ionotropic, AMPA 3 | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
GRIN2A | Glutamate receptor, ionotropic, N-methyl D-aspartate 2A | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enriched |
HM13 | Histocompatibility (minor) 13 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ITPR1 | Inositol 1,4,5-trisphosphate receptor, type 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
KIAA0195 | KIAA0195 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
MPDU1 | Mannose-P-dolichol utilization defect 1 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
MS4A8 | Membrane-spanning 4-domains, subfamily A, member 8 | Predicted membrane proteins
| | | | | Group enriched |
MT-ND3 | Mitochondrially encoded NADH dehydrogenase 3 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
NDFIP2 | Nedd4 family interacting protein 2 | Predicted membrane proteins
| | | | | Expressed in all |
ORAI1 | ORAI calcium release-activated calcium modulator 1 | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
PARL | Presenilin associated, rhomboid-like | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
PLLP | Plasmolipin | Predicted membrane proteins
| | | | | Mixed |
POPDC2 | Popeye domain containing 2 | Predicted membrane proteins
| | | | | Tissue enriched |
PQLC2 | PQ loop repeat containing 2 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
PRAF2 | PRA1 domain family, member 2 | Predicted membrane proteins
| | | | | Expressed in all |
PSEN1 | Presenilin 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PSEN2 | Presenilin 2 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PTGES | Prostaglandin E synthase | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
RER1 | Retention in endoplasmic reticulum sorting receptor 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
RHBDD1 | Rhomboid domain containing 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
RNF170 | Ring finger protein 170 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
RNF213 | Ring finger protein 213 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
RNFT2 | Ring finger protein, transmembrane 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
RP11-872D17.8 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000431536} | Predicted membrane proteins
| | | | | Tissue enhanced |
RPN2 | Ribophorin II | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
SCAMP4 | Secretory carrier membrane protein 4 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
SEC63 | SEC63 homolog (S. cerevisiae) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SEL1L3 | Sel-1 suppressor of lin-12-like 3 (C. elegans) | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
SGMS2 | Sphingomyelin synthase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
SLC11A2 | Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC12A1 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC12A5 | Solute carrier family 12 (potassium/chloride transporter), member 5 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC12A8 | Solute carrier family 12, member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |